Patent ID: 7563918

Claim:
A crystalline form of ibandronate sodium selected from the group consisting of: g) the crystalline form of ibandronate sodium characterized by x-ray reflections at about 4.6, 9.2, 18.3, 19.6, and 25.6±0.2° 2θ; r) the crystalline form of ibandronate sodium characterized by x-ray reflections at about 6.2, 25.9, 26.7, 31.1, and 37.2±0.2° 2θ; and u) the crystalline form of ibandronate sodium characterized by x-ray reflections at about 6.2, 15.7, 26.3, 32.6, and 35.6 ±0.2° 2θ.